Bison Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.52M Sell
1,974
-2,382
-55% -$1.97M 0.34% 64
2024
Q3
$3.86M Sell
4,356
-476
-10% -$428K 0.61% 32
2024
Q2
$3.76M Hold
4,832
0.61% 35
2024
Q1
$3.76M Sell
4,832
-176
-4% -$125K 0.61% 35
2023
Q4
$2.92M Buy
5,008
+504
+11% +$294K 0.52% 45
2023
Q3
$2.42M Buy
4,504
+546
+14% +$281K 0.47% 49
2023
Q2
$1.86M Buy
3,958
+1,823
+85% +$765K 0.34% 73
2023
Q1
$930K Buy
2,135
+36
+2% +$12.1K 0.29% 104
2022
Q4
$715K Buy
2,099
+189
+10% +$67K 0.23% 129
2022
Q3
$617K Buy
+1,910
New +$605K 0.24% 121

Other funds holding LLY

Bison Wealth's LLY Position: Q4 2024 in Review

Bison Wealth reduced its Eli Lilly (LLY) stake by 55% in Q4 2024, selling an estimated $1.97M and leaving 1,974 shares worth $1.52M. The position accounts for 0.34% of the portfolio, ranked #64.

Bison Wealth first reported a position in LLY in Q3 2022 and has held it in 10 quarters since. The position peaked at $3.86M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Bison Wealth held 1,974 shares of Eli Lilly worth $1.52M as of Q4 2024.
  • Bison Wealth sold 2,382 Eli Lilly shares in Q4 2024, an estimated $1.97M.
  • Eli Lilly made up 0.34% of Bison Wealth's portfolio in Q4 2024, its #64 holding.
  • Bison Wealth first reported a position in Eli Lilly in Q3 2022 and has held it in 10 quarters since.
  • Bison Wealth's Eli Lilly position peaked at $3.86M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.